![]() VIDEO: Elekta Harmony Radiotherapy System Walk-around VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare - Interview with Walter Curran, Jr. VIDEO: Advances in Radiopharmaceutical Therapy - Interview with Ana Kiess, M.D., Ph.D. VIDEO: 4 Radiation Oncology Technologies to Watch - Interview with Anthony Zietman, M.D. VIDEO: Sedating Children With Movies Rather Than Drugs for Radiation Therapy - Interview with Jeffrey T. Photo Gallery of Technologies at ASTRO 2021 Radiation Oncology Research Featured at ASTRO 2021 ![]() Related ASTRO 2021 Radiation Oncology Content:ħ Trends in Radiation Therapy at ASTRO 2021 If this trials shows benefits and low toxicity, followup studies will attempt more complex treatments in other parts of the body. PURPOSE OF MULTILEAF COLLIMATOR IN RADIOTHERAPY TRIALThis is the first human clinical trial of FLASH therapy, which centered on patients with metastases in arms and legs to avoid irradiating critical structures. It also would be a significant time and cost savings for patients and their families, who would not be required to stay at nearby hotels for extended stays during their course of treatment.Ĭincinnati Children's/UC Health Proton Therapy Center announced the completion of enrollment in FAST-01 ( FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases) in October. Reducing therapy to one treatment session also would open up much more time for proton centers so many more patients could be treated. If this and other trials show benefit and improved outcomes from FLASH, it is possible this may become the primary treatment method for many cancers in the years to come. Lab testing has shown this actually has a healthy tissue sparing capability and may help in reducing collateral damage. ![]() The premise of FLASH is to deliver extremely high doses of radiation to a tumor in one, short dose. This study is testing the use of a single FLASH proton therapy session, rather than weeks of fractionated doses.įLASH and hypo fractionated therapy have been among the hottest topics in radiation oncology. Breneman, M.D., medical director of the Cincinnati Children's/ UC Health Proton Therapy Center, and the principal investigator of the FAST-01 trial, explains FLASH therapy and details on the trial. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |